Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Telesis Bio Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
08/11/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/10/2023 8-K Quarterly results
Docs: "Telesis Bio Reports Second Quarter 2023 Financial Results -- Total revenue of $8.7M in 2QFY23 - increased by 53% year over year"
08/04/2023 EFFECT Form EFFECT - Notice of Effectiveness:
07/27/2023 S-3 Form S-3 - Registration statement under Securities Act of 1933:
07/07/2023 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
07/05/2023 SC 13G/A BroadOak Fund IV, LLC reports a 10.4% stake in Telesis Bio Inc.
07/05/2023 SC 13G/A GATTACA Mining LLC reports a 21.3% stake in Telesis Bio Inc.
06/09/2023 8-K Unregistered Sales of Equity Securities, Material Modifications to Rights of Security Holders, Departure of Directors or Cert...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549",
"Certificate of Designation of Redeemable Convertible Preferred Stock",
"Form of Warrant issued to an affiliate of H.C. Wainwright & Co., LLC",
"Telesis Bio Announces Closing of $28.0 Million Private Placement of Preferred Stock And Warrants to Purchase an Additional $46.2 Million of Common Stock"
06/08/2023 4 MEISTER PAUL M (10% Owner) has filed a Form 4 on Telesis Bio Inc.
Txns: Granted 108,270 shares @ $0
Granted 162,406 options to buy @ $1.33, valued at $216k
06/08/2023 3 Novalis LifeSciences Investments II GP, LLC (10% Owner) has filed a Form 3 on Telesis Bio Inc.
06/07/2023 4 Northpond Ventures GP, LLC (10% Owner) has filed a Form 4 on Telesis Bio Inc.
Txns: Granted 80,000 options to buy @ $100, valued at $8M
Granted 3,385,097 options to buy @ $0
Granted 1,692,549 options to buy @ $0
06/07/2023 SC 13D/A Northpond Ventures, LP reports a 47.9% stake in Telesis Bio Inc.
06/07/2023 4 BroadOak Fund IV, LLC (10% Owner) has filed a Form 4 on Telesis Bio Inc.
Txns: Granted 20,000 options to buy @ $2.3633, valued at $47.3k
Granted 423,137 options to buy @ $2.5996, valued at $1.1M
Granted 846,274 options to buy @ $2.5996, valued at $2.2M
06/07/2023 4 Snider William (10% Owner) has filed a Form 4 on Telesis Bio Inc.
Txns: Granted 20,000 options to buy @ $2.3633, valued at $47.3k
Granted 423,137 options to buy @ $2.5996, valued at $1.1M
Granted 846,274 options to buy @ $2.5996, valued at $2.2M
06/07/2023 4 Nelson Todd Robert (President & CEO) has filed a Form 4 on Telesis Bio Inc.
Txns: Granted 25,000 options to buy @ $2.3633, valued at $59.1k
Granted 528,922 options to buy @ $2.5996, valued at $1.4M
Granted 1,057,843 options to buy @ $2.5996, valued at $2.7M
06/02/2023 SC 13D/A Northpond Ventures, LLC reports a 33.1% stake in Telesis Bio Inc.
05/31/2023 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Material Modifications to Rights of Secu...
Docs: "Form of Certificate of Designation of Redeemable Convertible Preferred Stock",
"Form of Short-Term Warrant",
"Form of Long-Term Warrant",
"Form of Pre-Funded Common Stock Purchase Warrant",
"Redeemable Convertible Preferred Stock and Warrant Purchase Agreement",
"Form of Registration Rights Agreement",
"Amendment to Investors’ Rights Agreement",
"Telesis Bio Secures Financing of $28.0 Million Up to an Additional $46.2 Million Available Through Warrant Exercise Led by Novalis LifeSciences LLC with participation from NorthPond Ventures, M-185 Corporation and BroadOak Capital Partners"
05/24/2023 ARS Form ARS - Annual Report to Security Holders:
05/24/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
05/24/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
05/17/2023 10-K/A Annual Report for the period ended December 31, 2022 [amend]
05/12/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/11/2023 8-K Quarterly results
Docs: "Telesis Bio Reports First Quarter 2023 Financial Results -- Total revenue of $6.3M in 1QFY23 -- BioXp® franchise revenue increased by 28%"
05/08/2023 4 Nelson Todd Robert (President & CEO) has filed a Form 4 on Telesis Bio Inc.
Txns: Sold 2,575 shares @ $2.8261, valued at $7.3k
05/08/2023 4 Gibson Daniel Glenn (Chief Technology Officer) has filed a Form 4 on Telesis Bio Inc.
Txns: Sold 1,190 shares @ $2.8261, valued at $3.4k
05/08/2023 4 Cutler Rob (Chief Legal Officer) has filed a Form 4 on Telesis Bio Inc.
Txns: Sold 1,174 shares @ $2.8261, valued at $3.3k
05/05/2023 3 Cutler Rob (Chief Legal Officer) has filed a Form 3 on Telesis Bio Inc.
05/01/2023 10-K/A Annual Report for the period ended December 31, 2022 [amend]
04/18/2023 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
03/24/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
03/22/2023 10-K Annual Report for the period ended December 31, 2022
03/21/2023 8-K Quarterly results
Docs: "Telesis Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Guidance -- Record revenue of $9.5M in 4QFY22; Increase of 208% over 4QFY21 -- BioXp® Revenue increased by 158% to $3.4M, in 4QFY22 over 4QFY21"
02/14/2023 SC 13G/A GATTACA Mining LLC reports a 21.2% stake in Telesis Bio Inc.
01/27/2023 SC 13G/A DANAHER CORP reports a 7.8% stake in Telesis Bio Inc.
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy